$4.90 -0.02 (%) Orexigen Therapeutics Inc - NASDAQ

May. 29, 2015 | 04:00 PM

Partner Headlines

  1. Tuesday's After-Hours Movers: Vertex Pharmaceuticals, Orexigen Therapeutics And More

    Benzinga | May. 12, 2015 | 21:22PM EST
  2. Report: Orexigen Therapeutics Jumped Gun On Contrave Heart Study

    Benzinga | Mar. 3, 2015 | 21:07PM EST
  3. Contrave may help heart

    IBD | Mar. 3, 2015 | 18:29PM EST
  4. Orexigen Soars On Obesity Drug's Surprise Health Boon

    IBD | Mar. 3, 2015 | 13:54PM EST
  5. UPDATE: Orexigen Therapeutics Shares Drop After Q4 Results

    Benzinga | Feb. 25, 2015 | 09:36AM EST
  6. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  7. 5 Obesity Stocks Investors Are Watching

    Benzinga | Jan. 14, 2015 | 13:55PM EST
  8. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 2

    Benzinga | Jan. 12, 2015 | 11:03AM EST
  9. 4 Potential Blockbuster Drugs The FDA Just Approved

    IBD | Dec. 26, 2014 | 12:35PM EST
  10. Orexigen Therapeutics Gains On Diet Pill Nod From European Committee

    Benzinga | Dec. 19, 2014 | 14:09PM EST
  11. Friday's Big Gainers With High Short Interest

    Benzinga | Dec. 19, 2014 | 11:41AM EST
  12. How To Profit From The Obesity Epidemic

    Benzinga | Dec. 8, 2014 | 16:54PM EST
  13. These 4 Biotech Stocks Have Been On Fire

    Benzinga | Dec. 8, 2014 | 15:31PM EST
  14. 2 Skyrocketing Biotech Stocks In A Stalling Market

    Benzinga | Nov. 17, 2014 | 11:33AM EST
  15. What's Driving Orexigen Therapeutics Higher?

    Benzinga | Nov. 13, 2014 | 12:10PM EST
  16. Mid-Afternoon Market Update: Sothebys Climbs On Upbeat Revenue; GoPro Shares Dip

    Benzinga | Nov. 10, 2014 | 15:13PM EST
  17. Mid-Day Market Update: Gogo Shares Slide On Wider Loss; Achillion Pharmaceuticals Shares Jump

    Benzinga | Nov. 10, 2014 | 13:05PM EST
  18. Morning Market Movers

    Benzinga | Nov. 10, 2014 | 09:43AM EST
  19. 3 Pharma Companies Fighting Obesity

    Benzinga | Oct. 30, 2014 | 14:00PM EST
  20. Stocks Hitting 52-Week Lows

    Benzinga | Oct. 7, 2014 | 10:11AM EST
  21. Takeda And Orexigen Announce FDA Approval of Contrave Extended-release Tablets For Chronic Weight Management

    Benzinga | Sep. 11, 2014 | 07:01AM EST
  22. Benzinga's Top #PreMarket Losers

    Benzinga | Jul. 30, 2014 | 08:13AM EST
  23. Events Scheduled for Week of Jun. 16th to Jun. 20th

    Benzinga | Jun. 17, 2014 | 10:48AM EST
  24. FDA delays Orexigen drug

    IBD | Jun. 11, 2014 | 18:57PM EST
  25. Mid-Afternoon Market Update: ULTA Salon Remains Steady After Strong Results; Orexigen Still Down 15%

    Benzinga | Jun. 11, 2014 | 15:48PM EST
  26. Mid-Day Market Update: ULTA Salon Rises After Strong Results; Orexigen Shares Slide

    Benzinga | Jun. 11, 2014 | 12:34PM EST
  27. Orexigen Obesity Drug Decision Delayed By FDA

    IBD | Jun. 11, 2014 | 11:55AM EST
  28. Orexigen Shares Plummet Following FDA Decision; Competition Gets A Bump

    Benzinga | Jun. 11, 2014 | 11:24AM EST
  29. Mid-Morning Market Update: Markets Drop; H&R Block Posts Higher Profit

    Benzinga | Jun. 11, 2014 | 10:13AM EST
  30. Morning Market Losers

    Benzinga | Jun. 11, 2014 | 09:46AM EST
  31. Benzinga's Top #PreMarket Losers

    Benzinga | Jun. 11, 2014 | 08:09AM EST
  32. US Stock Futures Tumble; World Bank Lowers Global Growth Outlook

    Benzinga | Jun. 11, 2014 | 07:31AM EST
  33. Earnings Scheduled For March 12, 2014

    Benzinga | Mar. 12, 2014 | 05:09AM EST
  34. Benzinga's Top #PreMarket Losers

    Benzinga | Dec. 2, 2013 | 08:43AM EST
  35. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 26, 2013 | 08:10AM EST
  36. Mid-Afternoon Market Update: Markets Turn Back as Momentum Stocks Drop

    Benzinga | Nov. 25, 2013 | 15:48PM EST
  37. Mid-Day Market Update: SeaDrill Drops On Downbeat Earnings; Giant Interactive Shares Spike Higher

    Benzinga | Nov. 25, 2013 | 13:04PM EST
  38. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 25, 2013 | 08:12AM EST
  39. Orexigen Announces Successful Interim Analysis of Contrave Light Study, Will Resubmit Contrave NDA to FDA

    Benzinga | Nov. 25, 2013 | 07:04AM EST
  40. Orexigen, Takeda Report Multiple Contrave Data Presentations at ObesityWeek

    Benzinga | Nov. 11, 2013 | 16:31PM EST
  41. Obesity drugs up on report

    IBD | Oct. 3, 2013 | 18:50PM EST
  42. Vivus Weighs In As a Leader for Diet Pills, Cowen Upgrades and Raises PT

    Benzinga | Oct. 3, 2013 | 16:42PM EST
  43. Obesity Drug Stocks Jump As Cowen Gets Bullish

    IBD | Oct. 3, 2013 | 13:20PM EST
  44. Benzinga's Top Initiations

    Benzinga | Oct. 3, 2013 | 07:29AM EST
  45. Orexigen Submits Contrave Marketing Authorization Application to EMA

    Benzinga | Oct. 3, 2013 | 07:06AM EST
  46. Mid-Afternoon Market Update: DSW Rises as the NASDAQ Gets Crushed

    Benzinga | Aug. 27, 2013 | 15:37PM EST
  47. Benzinga's Top Pre-Market Gainers

    Benzinga | Aug. 27, 2013 | 08:20AM EST
  48. Orexigen Reports Progress on Resubmission of Contrave NDA, Sees Potential Approval in Early 2014

    Benzinga | Jan. 7, 2013 | 01:43AM EST
  49. Orexigen Concludes Light Study Patient Screening, to Randomize ~9,000 Patients, Sees Resubmission in Q4

    Benzinga | Dec. 18, 2012 | 01:36AM EST
  50. Orexigen Therapeutics Inc. Reports Operating Results (10-Q)

    GuruFocus | Nov. 9, 2012 | 01:33AM EST
Trading Center